All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Fri 2018-12-07? to Fri 2025-12-19 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| MRNA × |
−18.71%
2025-12-19 |
1.817 TR
2025-12-19 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Fri 2025-12-19 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+81.72%
+8.86%/yr |
+7.87%/yr
(R2=0.028) |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Fri 2025-12-19 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$18,172.04
2025-12-19 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Year | MRNA |
|---|---|
| 2025 (YTD) | −18.71% |
| 2024 | −58.19% |
| 2023 | −44.63% |
| 2022 | −29.28% |
| 2021 | +143.11% |
| 2020 | +434.10% |
| 2019 | +28.09% |
| 2018 | −17.90% |
| Fri 2018-12-07? to Fri 2025-12-19 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| MRNA × | −93.02% |
−95.38%
2025-11-20 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||